sanofi buys us haemophilia treatment firm
Last Updated : GMT 06:49:16
Arab Today, arab today
Arab Today, arab today
Last Updated : GMT 06:49:16
Arab Today, arab today

for $11.6 bn

Sanofi buys US haemophilia treatment firm

Arab Today, arab today

Arab Today, arab today Sanofi buys US haemophilia treatment firm

France's Sanofi is to buy Bioverativ.
Paris - Arab Today

French pharmaceutical firm Sanofi said Monday it had reached an agreement to purchase US biotech company Bioverativ, which specialises in treatments for haemophilia and rare blood disorders, for $11.6 billion.

Sanofi's chief executive Olivier Brandicourt said the acquisition "enhances its presence in specialty care and leadership in rare diseases... and creates a platform for growth in other rare blood disorders."

The purchase should also translate into a boost in profits per share beginning this year, rising to a gain of up to 5 percent in 2019, Sanofi said in a statement.

Bioverativ has latest-generation treatments for haemophilia, a disorder where blood does not clot properly to stop bleeding.

The haemophilia drugs market is "the largest market in rare diseases", worth around $10 billion per year and projected to grow by seven percent annually over the next five years, Brandicourt said in an audio conference with analysts.

He said he harboured a "strong admiration" for Bioverativ, which is a leader in the field with two drugs, Eloctate and Alprolix, already in the market and estimated overall sales of $1.2 billion in 2017.

Sanofi said it would be able to help Bioverativ with the research it has underway on the development of other haemophilia treatments, as well as for other rare diseases.

The agreement to purchase all of Bioverativ's outstanding shares for $105 each in cash represents a premium of 64 percent from the closing price on Friday, Sanofi said.

The operation is to start in February and close three months later, Brandicourt said.

But investors were not convinced, sending Sanofi's shares sharply lower on the Paris stock exchange as they wondered about the wisdom of putting so much money on the table.

The deal "looks logical, but expensive", with only modest potential to drive growth in the medium term, judged analysts at the Jefferies firm.

Furthermore, Sanofi may run into competition concerns from regulators with the takeover, they said.

The French firm said it would use funds on hand and borrow to finance the acquisition of Bioverativ.

But although pricey, the acquisition will still leave Sanofi with enough financial firepower to go after other acquisition targets, Jefferies said. One such target could be Pfizer's consumer healthcare business, they said.

The purchase of Bioverativ is the largest Sanofi has made since it acquired US biotech firm Genzyme for $20 billion in April 2011.

The French group failed in its 2016 bid to take over US cancer drugmaker Medivation which instead went to Pfizer.

Sanofi shares were 4.2 percent lower at 69.89 euros in late afternoon trading Monday, vastly underperforming the benchmark CAC 40 index in Paris which was up 0.2 percent.

 

Source: AFP

arabstoday
arabstoday

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

sanofi buys us haemophilia treatment firm sanofi buys us haemophilia treatment firm

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

sanofi buys us haemophilia treatment firm sanofi buys us haemophilia treatment firm

 



GMT 09:26 2017 Wednesday ,06 September

Kuwait condemns violations against Muslims in Myanmar

GMT 08:57 2017 Thursday ,06 April

Turkey says chemical weapons used in Syria attack

GMT 22:47 2016 Saturday ,17 December

Ajman to host International Pro Jiu-Jitsu Championship

GMT 14:52 2018 Friday ,14 December

Michel Aoun meets Rahi in Baabda

GMT 09:20 2017 Thursday ,13 April

Trump Discusses Syria Strikes with Merkel and May

GMT 06:07 2017 Tuesday ,14 February

Rain hits UAE, major traffic jams follow

GMT 12:01 2017 Thursday ,28 September

Ben Stokes included in England's Ashes squad

GMT 14:45 2017 Thursday ,16 March

El Jaish Win Qatar Men's Basketball League

GMT 12:27 2017 Tuesday ,01 August

Tangier Charms Gabonese President Ali Bongo

GMT 02:35 2017 Saturday ,04 February

Sharif calls for solution to Palestinian issue

GMT 08:45 2017 Friday ,03 November

Apple delivers higher profit

GMT 11:27 2017 Wednesday ,08 February

First Turkish minister visits Israel since 2010

GMT 02:11 2017 Friday ,08 December

Princess Sabeeka receives UN Women executive director

GMT 12:43 2017 Saturday ,25 February

Shaikh Nasser following up on injured rider's health

GMT 05:20 2017 Tuesday ,24 October

Anti-Kremlin activist Browder blocked from US

GMT 21:16 2017 Sunday ,26 February

Two German archaeologists kidnapped in Nigeria freed

GMT 22:48 2016 Wednesday ,30 November

Egypt wins EuroMed Postal Union membership

GMT 07:11 2017 Thursday ,09 February

Portuguese president has lunch with refugees

GMT 11:33 2017 Sunday ,03 December

After hot debate, US tax bill a boon to businesses
Arab Today, arab today
 
 Arab Today Facebook,arab today facebook  Arab Today Twitter,arab today twitter Arab Today Rss,arab today rss  Arab Today Youtube,arab today youtube  Arab Today Youtube,arab today youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©

arabstoday arabstoday arabstoday arabstoday
arabstoday arabstoday arabstoday
arabstoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
arabstoday, Arabstoday, Arabstoday